Cargando…
The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
PURPOSE: Circulating tumor cells (CTCs) are considered potential biomarkers for the detection of hepatocellular carcinoma (HCC). Many studies have attempted to explore this role, but the results are variable. We conducted the first comprehensive meta-analysis to evaluate the diagnostic value of CTC...
Autores principales: | Sun, Chi, Liao, Wenjun, Deng, Zefu, Li, Enliang, Feng, Qian, Lei, Jun, Yuan, Rongfa, Zou, Shubing, Mao, Yilei, Shao, Jianghua, Wu, Linquan, Zhang, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521903/ https://www.ncbi.nlm.nih.gov/pubmed/28723763 http://dx.doi.org/10.1097/MD.0000000000007513 |
Ejemplares similares
-
Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma: A Meta-Analysis
por: Liao, Wenjun, et al.
Publicado: (2015) -
Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up
por: Xu, Wei, et al.
Publicado: (2016) -
TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma
por: Li, Yong, et al.
Publicado: (2022) -
Diagnostic value of circulating tumor DNA in molecular characterization of glioma: A meta-analysis
por: Kang, Yin, et al.
Publicado: (2020) -
IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling
por: Min, Jiaqi, et al.
Publicado: (2018)